The invention provides a method for the mass production of nicotinamide mononucleotide (NMN) via fermentation in genetically engineered yeast strains.
NMN has been shown to repair cellular DNA damage and may have anti-ageing effects. Animal studies have shown mid-aged mice taking this vitamin lived 20% longer and were able to run faster than the mice in a control group. Despite the promising effects, NMN synthesised enzymatically may need to be purified.
- Mass production
- May be cheaper to produce than chemical synthesis
- The core technology has been patented
- To develop an anti-ageing medication for human and veterinary use
This technology is available for free as an Easy Access IP Licence.
UNSW is seeking a partner to license this technology or to work with the researchers to further develop this technology.